Fracanzani Anna Ludovica, Tiraboschi Silvia, Pisano Giuseppina, Consonni Dario, Baragetti Andrea, Bertelli Cristina, Norata Danilo, Valenti Luca, Grigore Liliana, Porzio Marianna, Catapano Alberico, Fargion Silvia
Department of Pathophysiology and Transplantation, Ca' Granda Foundation IRCCS Maggiore Policlinico Hospital, University of Milan, Milan, Italy.
Epidemiology Unit, Ca' Granda Foundation IRCCS Maggiore Policlinico Hospital, University of Milan, Milan, Italy.
Atherosclerosis. 2016 Mar;246:208-13. doi: 10.1016/j.atherosclerosis.2016.01.016. Epub 2016 Jan 12.
Non-alcoholic fatty liver disease (NAFLD) is associated not only with liver related morbidity and mortality but also with an increased risk of cardiovascular disease.
to evaluate in patients with NAFLD and in matched Controls after 10 years of follow-up 1 the incidence of major cardiovascular and cerebral events 2 the progression of vascular damage.
Clinical and cardio-metabolic data were collected in 125 NAFLD patients and 250 age and gender matched Controls at baseline and 10 years later. Incidence of cardiovascular and cerebral events was recorded. By ultrasonography, carotid intima-media thickness (cIMT), presence of plaques and presence of fatty liver were evaluated.
25% of the overall series was lost to follow-up. Sixty-eight (37%) Controls developed steatosis. Major cardiovascular events were observed in thirty-five subjects (17/91 (19%) NAFLD and 18/182 (10%) Controls), with an estimated cumulative risk significantly higher in NAFLD than in Controls, log-rank test for equality of failure functions p = 0.007. At multivariate analysis, presence of plaques (hazard ratio 5.08 (95% C.I. 2.56-10.96) and of steatosis (hazard ratio 1.99 (1.01-3.94)) were the strongest predictors for cardiovascular events. Grade of steatosis, ALT and GGT levels were higher in NAFLD patients who developed cardiovascular events. cIMT value after 10 years was significantly higher in NAFLD than in Controls, but the mean progression rate was higher in Controls (0.015 and 0.006 mm/year, p = 0.001). In conclusion our results suggest that NAFLD has to be included among risk factors for cardiovascular damage and underline the utility to evaluate, once NAFLD is diagnosed, the presence of atherosclerotic lesions.
非酒精性脂肪性肝病(NAFLD)不仅与肝脏相关的发病率和死亡率有关,还与心血管疾病风险增加相关。
对NAFLD患者及匹配的对照组进行10年随访,评估1. 主要心血管和脑血管事件的发生率;2. 血管损伤的进展情况。
收集125例NAFLD患者及250例年龄和性别匹配的对照组在基线和10年后的临床及心脏代谢数据。记录心血管和脑血管事件的发生率。通过超声检查评估颈动脉内膜中层厚度(cIMT)、斑块的存在情况及脂肪肝的存在情况。
整个队列中有25%失访。68例(37%)对照组出现脂肪变性。在35名受试者中观察到主要心血管事件(17/91(19%)NAFLD患者和18/182(10%)对照组),NAFLD患者的估计累积风险显著高于对照组,失效函数相等性的对数秩检验p = 0.007。多因素分析显示,斑块的存在(风险比5.08(95%置信区间2.56 - 10.96))和脂肪变性的存在(风险比1.99(1.01 - 3.94))是心血管事件的最强预测因素。发生心血管事件的NAFLD患者的脂肪变性程度、ALT和GGT水平更高。10年后NAFLD患者的cIMT值显著高于对照组,但对照组的平均进展率更高(分别为0.015和0.006 mm/年,p = 0.001)。总之,我们的结果表明,NAFLD应被纳入心血管损伤的危险因素中,并强调一旦诊断出NAFLD,评估动脉粥样硬化病变存在情况的实用性。